Micheal C. Perry

Randomized Phase III Intergroup Trial of Etoposide and Cisplatin With or Without Paclitaxel and Granulocyte Colony-Stimulating Factor in Patients With Extensive-Stage Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 9732

Harvey B. Niell, James E. Herndon, Antonius A. Miller et al. · Journal of Clinical Oncology · 2005 · 188 citations

Medicine, Oncology, Pharmacology +11

CALGB Study 9431: A randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy (Ind CT) and concomitant chemoradiotherapy (XRT) for unresectable stage III non-small cell lung cancer (NSCLC)

Everett E. Vokes, K. Leopold, James E. Herndon et al. · Lung Cancer · 2000 · 49 citations

Medicine, Oncology, Pharmacology +16

2 Randomized prospective comparison of adjuvant mediastinal radiation (RT) with or without concurrent chemotherapy with cisplatin and etoposide (PE) for patients with completely resected 51-3N1-2M0 non-small cell lung cancer (NSCLC): US

Stefan M. Keller, S. Adak, H J Wagner et al. · International Journal of Radiation Oncology*Biology*Physics · 1999 · 16 citations

Medicine, Oncology, Radiation Oncology +17